Results 151 to 160 of about 21,376,824 (184)
Some of the next articles are maybe not open access.

P-glycoprotein and multidrug resistance

Current Opinion in Genetics & Development, 1996
Although the phenomenon of simultaneous resistance to multiple cytotoxic drugs (multidrug resistance) in cancer cells has been discussed for more than two decades, and the human and mouse genes encoding an energy-dependent transporter (the multidrug transporter or P-glycoprotein) responsible for multidrug resistance were cloned 10 years ago, there is ...
M M, Gottesman, I, Pastan, S V, Ambudkar
openaire   +4 more sources

Photoaffinity substrates for P-glycoprotein

Biochemical Pharmacology, 1992
A variety of compounds can inhibit the function of P-glycoprotein (Pgp) by binding to it and preventing the efflux of anticancer drug substrates. While the molecular architecture of the drug binding site(s) in Pgp is not known, it is clear that modulators in general appear to conform to some general physical-chemical rules.
W T, Beck, X D, Qian
openaire   +2 more sources

Structural and functional aspects of P‐glycoprotein and its inhibitors

Life Science, 2018
P‐glycoprotein (P‐gp) is a member of ATP‐binding cassette (ABC) superfamily which extrudes chemotherapeutic agents out of the cell. Suppression of this efflux activity has been the subject of numerous attempts to develop P‐gp inhibitors.
Shirin Mollazadeh   +4 more
semanticscholar   +1 more source

The P-glycoprotein multidrug transporter

General Pharmacology: The Vascular System, 1996
1. P-glycoprotein (P-gp) is a transmembrane protein involved in ATP-dependent efflux of various structurally unrelated anticancer drugs. Its overexpression in cancer cells decreases intracellular drug concentrations and, thus, confers a multidrug resistance phenotype. 2.
O, Fardel, V, Lecureur, A, Guillouzo
openaire   +2 more sources

P-glycoproteins in nematodes

Parasitology Today, 1994
The P-glycoprotein (Pgp), a member of a group of integral membrane proteins that contain the ATP-binding cassette, is widely represented in the animal kingdom. A family of Pgp homologues has recently been described in nematodes. Pgps have been implicated in drug resistance in Plasmodium and in other parasitic protozoa, so the interest of ...
openaire   +2 more sources

P-glycoprotein in breast cancer

1989
Resistance to cytotoxic chemotherapy is a major impediment to the successful treatment of breast cancer. Adjuvant chemotherapy, though given under theoretically optimal conditions of low tumor bulk [1], often fails to eradicate micrometastasis.
D E, Merkel, S A, Fuqua, W L, McGuire
openaire   +2 more sources

Cytokine Regulation of P-Glycoprotein

Drug Metabolism Reviews, 2003
P-glycoprotein (Pgp) is a membrane bound transporter involved in the disposition of many endogenous compounds and xenobiotics. Alterations in Pgp expression and activity can significantly affect the disposition of Pgp substrates. Infection and inflammatory stimuli have also been shown to alter drug disposition.
Mary Peace, McRae   +2 more
openaire   +2 more sources

Photoaffinity Labeling of P-Glycoprotein

Mini-Reviews in Medicinal Chemistry, 2005
The aim of the present review is to summarize recent progress in identifying substrate binding domains of P-glycoprotein by photoaffinity labeling. Preferred substrate binding regions have been identified using a number of photoaffinity ligands, including anthracyclines, the quinazoline iodoarylazidoprazosine (IAAP), dihydropyridines, taxanes and ...
Michael, Peer   +4 more
openaire   +2 more sources

P-glycoprotein in autoimmune diseases

Autoimmunity Reviews, 2004
Multidrug resistance-1 (MDR-1) is characterized by overfunction of P-glycoprotein (P-gp), a pump molecule that decreases intracellular drug concentration by effluxing them from the intracellular space. Broad ranges of structurally unrelated compounds are transported by P-gp, including antineoplastic agents, HIV protease inhibitors, prednisone, gold ...
Yvonne, Richaud-Patin   +3 more
openaire   +2 more sources

P-Glycoproteins and Multidrug Resistance

Annual Review of Pharmacology and Toxicology, 1996
Multidrug resistance represents a major obstacle in the successful therapy of neoplastic diseases. Studies have demonstrated that this form of drug resistance occurs both in cultured tumor cell lines as well as in human cancers. P-glycoprotein appears to play an important role in such cells by acting as an energy-dependent efflux pump to remove various
openaire   +2 more sources

Home - About - Disclaimer - Privacy